Oppenheimer raises Teva stock price target on Weltruza approval
Related news
-
Advances In The AI-Mind-Body Psychophysiological Connection Require These Vital Research Pursuits
-
French fiscal risks raise chance of ECB pause after December
- Wall Street Week Ahead: Bank earnings, CPI headline busy markets week as S&P 500 hovers near records
- Euro falls, set for fifth straight weekly drop as oil prices rise
- IT stocks surge despite US immigration curbs
- Gold hits one-week high, heads for weekly gain on bargain-hunting
- Poonawalla Fincorp Q2 profit soars five-fold YoY to Rs 375 crore
- Rupee rises to intra-day high, then slips on dollar demand